USE OF FXR AGONISTS FOR TREATING AN INFECTION BY HEPATITIS D VIRUS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230060715A1
SERIAL NO

17787956

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of a farnesoid X receptor (FXR) agonist for the treatment of hepatitis D infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE75007 PARIS
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)PARIS FRANCE PARIS PARIS
UNIVERSITE CLAUDE BERNARD LYON 143 BOULEVARD DU 11 NOVEMBRE 1918 VILLEURBANNE 69100
ECOLE NORMALE SUPERIEURE DE LYON15 PARVIS RENÉ DESCARTES BP 7000 LYON 69342
ENYO PHARMA60 AVENUE ROCKEFELLER BIOSERRA 1 - BÂTIMENT B LYON 69008

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ANDRE, PATRICE LYON, FR 59 221
DARTEIL, RAPHAËL LYON, FR 17 13
DURANTEL, DAVID GENAS, FR 10 79
LACOMBE, BENOÎT RENENS VD, CH 1 0
LOTTEAU, VINCENT VOURLES, FR 25 69
LUCIFORA, JULIE LYON, FR 1 0
RAMIERE, CHRISTOPHE LYON, FR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation